Study guide
12.4 Targeted Temperature Management After Cardiac Arrest
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
12.4 Targeted Temperature Management After Cardiac Arrest
Key Takeaways Explain This Topic AI
The 2023 AHA focused update on adult ACLS renamed targeted temperature management as temperature control: all adults who do not follow commands after ROSC, regardless of arrest location or initial rhythm, should receive a deliberate temperature control strategy (Class 1, LOE B-R).
Select and maintain a constant temperature anywhere between 32 and 37.5 degrees C (Class 1, LOE B-R) and hold it for at least 24 hours (Class 2a) - cooling every patient to 33 degrees C is no longer the standard.
Rapid infusion of cold intravenous fluid for prehospital cooling is not recommended (Class 3, No Benefit), and spontaneously hypothermic unresponsive patients should not be rewarmed faster than about 0.5 degrees C per hour.
Shivering defeats the therapy: score it with the Bedside Shivering Assessment Scale (0-3, goal 0-1) and escalate stepwise through counterwarming, acetaminophen, magnesium, buspirone, opioids, dexmedetomidine and propofol, using neuromuscular blockade only with adequate sedation.
Potassium shifts intracellularly during cooling and rebounds out during rewarming, so replacement given late in the maintenance phase can produce dangerous hyperkalemia - stop supplementation before rewarming begins and rewarm at 0.25-0.5 degrees C per hour.
Last updated: August 2026
What Changed, and Why It Matters for the Exam
A CMC candidate who studied from older material will answer temperature questions wrong. The teaching that every comatose survivor of ventricular fibrillation arrest is cooled to 32-34 degrees C is retired .
The 2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support , published in Circulation in 2024, deliberately renamed the intervention from targeted temperature management to temperature control and set the following recommendations:
Recommendation Class / LOE
All adults who do not follow commands after ROSC , irrespective of arrest location or presenting rhythm, receive treatment that includes a deliberate strategy for temperature control Class 1 , LOE B-R
Select and maintain a constant temperature between 32 and 37.5 degrees C during post-arrest temperature control Class 1 , LOE B-R
Maintain the selected target for at least 24 hours after achieving it Class 2a , LOE B-NR
Actively prevent fever in patients who remain unresponsive after the initial temperature control period Class 2b, LOE C-LD
Do not routinely rewarm spontaneously hypothermic unresponsive post-ROSC patients faster than 0.5 degrees C per hour Class 2b, LOE C-EO
Do not routinely use rapid infusion of cold intravenous fluid for prehospital cooling after ROSC Class 3 (No Benefit) , LOE B-R
The Trial History Behind the Change
HACA and Bernard (2002) - two small trials in out-of-hospital ventricular fibrillation arrest showed improved neurologic outcome with 12-24 hours of cooling to 32-34 degrees C. These created the therapeutic hypothermia era.
TTM1 (2013) - 950 patients randomized to a target of 33 versus 36 degrees C found no difference in mortality or neurologic outcome. The reading was that active temperature control mattered and that 33 was not superior to 36.
TTM2 (2021) - 1,850 patients randomized to hypothermia at 33 degrees C versus normothermia with active fever prevention (treat if temperature reaches 37.8) again found no difference in 6-month mortality or functional outcome, with more arrhythmia causing hemodynamic compromise in the hypothermia arm.
The guideline widened the acceptable range to 32-37.5 degrees C precisely because the trials could not show one target beating another - while continuing to require that a target be chosen deliberately and held, because fever after arrest is consistently associated with worse neurologic outcome . The practical upshot at the bedside: institutions differ, many now default to 36 or 37 degrees C, and lower targets are still used selectively. The nurse's job is not to argue the number but to hold whichever number is prescribed without drift.
Why Temperature Control at All: Post-Cardiac-Arrest Syndrome
After return of spontaneous circulation (ROSC) four processes run in parallel and drive the mortality that follows a technically successful resuscitation:
Anoxic brain injury - excitotoxicity, calcium influx, free radical generation, mitochondrial failure, and delayed apoptosis over hours to days; loss of cerebral autoregulation makes the brain pressure-passive and vulnerable to both hypotension and hyperoxia.
Post-arrest myocardial dysfunction - global stunning with a depressed ejection fraction that typically nadirs at 8-24 hours and recovers over 48-72 hours; commonly needs inotropic support and is reversible.
Systemic ischemia-reperfusion response - a sepsis-like state with vasoplegia, capillary leak, coagulation activation, adrenal suppression, and rising lactate.
Persistent precipitating pathology - the acute coronary occlusion, pulmonary embolism, hemorrhage, electrolyte disorder, or toxin that caused the arrest and still needs treating.
Temperature control lowers cerebral metabolic rate (roughly 6-8% per degree C), reduces excitotoxicity, inflammation, and free radical production, and above all prevents the fever that worsens all of it.